Skip Nav Destination
The wacky hypercoagulable state of malignancy
A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4)
Issue Archive
July 23 2015
Table of Contents
EDITORIAL
INSIDE BLOOD COMMENTARIES
INSIDE BLOOD COMMENTARY
The wacky hypercoagulable state of malignancy
Clinical Trials & Observations
PLENARY PAPER
TRANSPLANTATION
Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD
Martin Chopra,Andreas Brandl,Daniela Siegmund,Anja Mottok,Viktoria Schäfer,Marlene Biehl,Sabrina Kraus,Carina A. Bäuerlein,Miriam Ritz,Katharina Mattenheimer,Stefanie Schwinn,Axel Seher,Thomas Grabinger,Hermann Einsele,Andreas Rosenwald,Thomas Brunner,Andreas Beilhack,Harald Wajant
REVIEW SERIES
REVIEW SERIES
REVIEW SERIES
REVIEW SERIES
REVIEW SERIES
CLINICAL TRIALS AND OBSERVATIONS
A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4)
Clinical Trials & Observations
Brief Report
IMMUNOBIOLOGY
LYMPHOID NEOPLASIA
PLATELETS AND THROMBOPOIESIS
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
BLOOD WORK
CORRESPONDENCE
-
Cover Image
Cover Image
Mitochondria and F-actin localization during megakaryocyte morphogenesis. Shown is a collage of 3 different immunostained fetal liver megakaryocytes at various stages of differentiation stained for mitochondria (red), F-actin (green), and DNA (blue). Images were acquired on a Zeiss LSM780 laser scanning confocal microscope (×100 objective, zoom 2). See the article by Sui et al on page 520.
- PDF Icon Front MatterFront Matter
- PDF Icon Table of ContentsTable of Contents
- PDF Icon Back MatterBack Matter
- PDF Icon AdvertisingAdvertising
- PDF Icon Editorial BoardEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals